Lineage Cell Therapeutics Stock Market Value
| LCTX Stock | USD 0.57 0.04 6.56% |
| Symbol | Lineage |
Lineage Cell Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lineage Cell. If investors know Lineage will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lineage Cell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.10) | Revenue Per Share 0.034 | Quarterly Revenue Growth (0.56) | Return On Assets (0.13) | Return On Equity (0.35) |
The market value of Lineage Cell Therapeutics is measured differently than its book value, which is the value of Lineage that is recorded on the company's balance sheet. Investors also form their own opinion of Lineage Cell's value that differs from its market value or its book value, called intrinsic value, which is Lineage Cell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lineage Cell's market value can be influenced by many factors that don't directly affect Lineage Cell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lineage Cell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lineage Cell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lineage Cell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Lineage Cell 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Lineage Cell's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Lineage Cell.
| 09/03/2024 |
| 12/02/2024 |
If you would invest 0.00 in Lineage Cell on September 3, 2024 and sell it all today you would earn a total of 0.00 from holding Lineage Cell Therapeutics or generate 0.0% return on investment in Lineage Cell over 90 days. Lineage Cell is related to or competes with MAIA Biotechnology, Armata Pharmaceuticals, Portage Biotech, Cadrenal Therapeutics,, ImmuCell, Oxford Nanopore, and Replimune. Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment... More
Lineage Cell Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Lineage Cell's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Lineage Cell Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.10) | |||
| Maximum Drawdown | 39.6 | |||
| Value At Risk | (6.25) | |||
| Potential Upside | 7.14 |
Lineage Cell Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lineage Cell's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Lineage Cell's standard deviation. In reality, there are many statistical measures that can use Lineage Cell historical prices to predict the future Lineage Cell's volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.72) | |||
| Total Risk Alpha | (1.40) | |||
| Treynor Ratio | (0.22) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lineage Cell's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Lineage Cell Therapeutics Backtested Returns
Lineage Cell Therapeutics has Sharpe Ratio of -0.0868, which conveys that the firm had a -0.0868% return per unit of risk over the last 3 months. Lineage Cell exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Lineage Cell's Risk Adjusted Performance of (0.05), standard deviation of 5.66, and Mean Deviation of 3.59 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 2.07, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Lineage Cell will likely underperform. At this point, Lineage Cell Therapeutics has a negative expected return of -0.5%. Please make sure to verify Lineage Cell's total risk alpha, kurtosis, as well as the relationship between the Kurtosis and market facilitation index , to decide if Lineage Cell Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.48 |
Average predictability
Lineage Cell Therapeutics has average predictability. Overlapping area represents the amount of predictability between Lineage Cell time series from 3rd of September 2024 to 18th of October 2024 and 18th of October 2024 to 2nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Lineage Cell Therapeutics price movement. The serial correlation of 0.48 indicates that about 48.0% of current Lineage Cell price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.48 | |
| Spearman Rank Test | 0.21 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Lineage Cell Therapeutics lagged returns against current returns
Autocorrelation, which is Lineage Cell stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Lineage Cell's stock expected returns. We can calculate the autocorrelation of Lineage Cell returns to help us make a trade decision. For example, suppose you find that Lineage Cell has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Lineage Cell regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Lineage Cell stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Lineage Cell stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Lineage Cell stock over time.
Current vs Lagged Prices |
| Timeline |
Lineage Cell Lagged Returns
When evaluating Lineage Cell's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Lineage Cell stock have on its future price. Lineage Cell autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Lineage Cell autocorrelation shows the relationship between Lineage Cell stock current value and its past values and can show if there is a momentum factor associated with investing in Lineage Cell Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Lineage Stock Analysis
When running Lineage Cell's price analysis, check to measure Lineage Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lineage Cell is operating at the current time. Most of Lineage Cell's value examination focuses on studying past and present price action to predict the probability of Lineage Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lineage Cell's price. Additionally, you may evaluate how the addition of Lineage Cell to your portfolios can decrease your overall portfolio volatility.